Ken Griffin Ark Genomic Revolution ETF (De Transaction History
Citadel Advisors LLC
- $559 Billion
- Q4 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Citadel Advisors LLC holds 750,000 shares of ARKG stock, worth $22.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
750,000
Previous 614,900
21.97%
Holding current value
$22.1 Million
Previous $15.7 Million
12.2%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding ARKG
# of Institutions
284Shares Held
21.2MCall Options Held
2.81MPut Options Held
2.51M-
Goldman Sachs Group Inc New York, NY3.63MShares$107 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.48MShares$103 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.79MShares$82.1 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC2.78MShares$81.9 Million0.01% of portfolio
-
Citigroup Inc1.66MShares$48.7 Million0.02% of portfolio